Selected article for: "pair sample and sample size"
Author: Jennifer C.E Lane; James Weaver; Kristin Kostka; Talita Duarte-Salles; Maria Tereza F. Abrahao; Heba Alghoul; Osaid Alser; Thamir M Alshammari; Patricia Biedermann; Edward Burn; Paula Casajust; Mitch Conover; Aedin C. Culhane; Alexander Davydov; Scott L. DuVall; Dmitry Dymshyts; Sergio Fernández Bertolín; Kristina Fišter; Jill Hardin; Laura Hester; George Hripcsak; Seamus Kent; Sajan Khosla; Spyros Kolovos; Christophe G. Lambert; Johan ver der Lei; Ajit A. Londhe; Kristine E. Lynch; Rupa Makadia; Andrea V. Margulis; Michael E. Matheny; Paras Mehta; Daniel R. Morales; Henry Morgan-Stewart; Mees Mosseveld; Danielle Newby; Fredrik Nyberg; Anna Ostropolets; Rae Woong Park; Albert Prats-Uribe; Gowtham A. Rao; Christian Reich; Jenna Reps; Peter Rijnbeek; Selva Muthu Kumaran Sathappan; Martijn Schuemie; Sarah Seager; Anthony Sena; Azza Shoaibi; Matthew Spotnitz; Marc A. Suchard; Joel Swerdel; Carmen Olga Torre; David Vizcaya; Haini Wen; Marcel de Wilde; Seng Chan You; Lin Zhang; Oleg Zhuk; Patrick Ryan; Daniel Prieto-Alhambra
Title: Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
  • Document date: 2020_4_10
    • ID: 2hbcbvt6_36
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20054551 doi: medRxiv preprint in each of the available databases. The MDRRs for each of the databases for each drug pair-outcome analysis, as well as sample size for each of the comparisons are reported in full in an interactive web app (https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/. Only analyses with 0 counts in either.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20054551 doi: medRxiv preprint in each of the available databases. The MDRRs for each of the databases for each drug pair-outcome analysis, as well as sample size for each of the comparisons are reported in full in an interactive web app (https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/. Only analyses with 0 counts in either treatment group were excluded based on power, with all others contributing to meta-analytic estimates where applicable.

    Search related documents:
    Co phrase search for related documents
    • comparison sample size and sample size: 1, 2, 3, 4, 5, 6
    • drug pair outcome analysis and pair outcome: 1
    • drug pair outcome and pair outcome: 1, 2
    • interactive web app and web app: 1, 2, 3, 4, 5, 6
    • meta analytic estimate and sample size: 1
    • sample size and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • sample size and treatment group:1 0:count: 1
    • sample size and web app: 1, 2, 3, 4
    • treatment group and web app: 1